Cargando…

Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells

BACKGROUND: Although profiling of RNA in single cells has broadened our understanding of development, cancer biology and mechanisms of disease dissemination, it requires the development of reliable and flexible methods. Here we demonstrate that the EpiStem RNA-Amp™ methodology reproducibly generates...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothwell, Dominic G, Li, Yaoyong, Ayub, Mahmood, Tate, Catriona, Newton, Gillian, Hey, Yvonne, Carter, Louise, Faulkner, Suzanne, Moro, Massimo, Pepper, Stuart, Miller, Crispin, Blackhall, Fiona, Bertolini, Giulia, Roz, Luca, Dive, Caroline, Brady, Ged
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320548/
https://www.ncbi.nlm.nih.gov/pubmed/25519510
http://dx.doi.org/10.1186/1471-2164-15-1129
_version_ 1782356138757455872
author Rothwell, Dominic G
Li, Yaoyong
Ayub, Mahmood
Tate, Catriona
Newton, Gillian
Hey, Yvonne
Carter, Louise
Faulkner, Suzanne
Moro, Massimo
Pepper, Stuart
Miller, Crispin
Blackhall, Fiona
Bertolini, Giulia
Roz, Luca
Dive, Caroline
Brady, Ged
author_facet Rothwell, Dominic G
Li, Yaoyong
Ayub, Mahmood
Tate, Catriona
Newton, Gillian
Hey, Yvonne
Carter, Louise
Faulkner, Suzanne
Moro, Massimo
Pepper, Stuart
Miller, Crispin
Blackhall, Fiona
Bertolini, Giulia
Roz, Luca
Dive, Caroline
Brady, Ged
author_sort Rothwell, Dominic G
collection PubMed
description BACKGROUND: Although profiling of RNA in single cells has broadened our understanding of development, cancer biology and mechanisms of disease dissemination, it requires the development of reliable and flexible methods. Here we demonstrate that the EpiStem RNA-Amp™ methodology reproducibly generates microgram amounts of cDNA suitable for RNA-Seq, RT-qPCR arrays and Microarray analysis. RESULTS: Initial experiments compared amplified cDNA generated by three commercial RNA-Amplification protocols (Miltenyi μMACS™ SuperAmp™, NuGEN Ovation® One-Direct System and EpiStem RNA-Amp™) applied to single cell equivalent levels of RNA (25–50 pg) using Affymetrix arrays. The EpiStem RNA-Amp™ kit exhibited the highest sensitivity and was therefore chosen for further testing. A comparison of Affymetrix array data from RNA-Amp™ cDNA generated from single MCF7 and MCF10A cells to reference controls of unamplified cDNA revealed a high degree of concordance. To assess the flexibility of the amplification system single cell RNA-Amp™ cDNA was also analysed using RNA-Seq and high-density qPCR, and showed strong cross-platform correlations. To exemplify the approach we used the system to analyse RNA profiles of small populations of rare cancer initiating cells (CICs) derived from a NSCLC patient-derived xenograft. RNA-Seq analysis was able to identify transcriptional differences in distinct subsets of CIC, with one group potentially enriched for metastasis formation. Pathway analysis revealed that the distinct transcriptional signatures demonstrated in the CIC subpopulations were significantly correlated with published stem-cell and epithelial-mesenchymal transition signatures. CONCLUSIONS: The combined results confirm the sensitivity and flexibility of the RNA-Amp™ method and demonstrate the suitability of the approach for identifying clinically relevant signatures in rare, biologically important cell populations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2164-15-1129) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4320548
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43205482015-02-08 Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells Rothwell, Dominic G Li, Yaoyong Ayub, Mahmood Tate, Catriona Newton, Gillian Hey, Yvonne Carter, Louise Faulkner, Suzanne Moro, Massimo Pepper, Stuart Miller, Crispin Blackhall, Fiona Bertolini, Giulia Roz, Luca Dive, Caroline Brady, Ged BMC Genomics Research Article BACKGROUND: Although profiling of RNA in single cells has broadened our understanding of development, cancer biology and mechanisms of disease dissemination, it requires the development of reliable and flexible methods. Here we demonstrate that the EpiStem RNA-Amp™ methodology reproducibly generates microgram amounts of cDNA suitable for RNA-Seq, RT-qPCR arrays and Microarray analysis. RESULTS: Initial experiments compared amplified cDNA generated by three commercial RNA-Amplification protocols (Miltenyi μMACS™ SuperAmp™, NuGEN Ovation® One-Direct System and EpiStem RNA-Amp™) applied to single cell equivalent levels of RNA (25–50 pg) using Affymetrix arrays. The EpiStem RNA-Amp™ kit exhibited the highest sensitivity and was therefore chosen for further testing. A comparison of Affymetrix array data from RNA-Amp™ cDNA generated from single MCF7 and MCF10A cells to reference controls of unamplified cDNA revealed a high degree of concordance. To assess the flexibility of the amplification system single cell RNA-Amp™ cDNA was also analysed using RNA-Seq and high-density qPCR, and showed strong cross-platform correlations. To exemplify the approach we used the system to analyse RNA profiles of small populations of rare cancer initiating cells (CICs) derived from a NSCLC patient-derived xenograft. RNA-Seq analysis was able to identify transcriptional differences in distinct subsets of CIC, with one group potentially enriched for metastasis formation. Pathway analysis revealed that the distinct transcriptional signatures demonstrated in the CIC subpopulations were significantly correlated with published stem-cell and epithelial-mesenchymal transition signatures. CONCLUSIONS: The combined results confirm the sensitivity and flexibility of the RNA-Amp™ method and demonstrate the suitability of the approach for identifying clinically relevant signatures in rare, biologically important cell populations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2164-15-1129) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-17 /pmc/articles/PMC4320548/ /pubmed/25519510 http://dx.doi.org/10.1186/1471-2164-15-1129 Text en © Rothwell et al.; licensee BioMed Central. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Rothwell, Dominic G
Li, Yaoyong
Ayub, Mahmood
Tate, Catriona
Newton, Gillian
Hey, Yvonne
Carter, Louise
Faulkner, Suzanne
Moro, Massimo
Pepper, Stuart
Miller, Crispin
Blackhall, Fiona
Bertolini, Giulia
Roz, Luca
Dive, Caroline
Brady, Ged
Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells
title Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells
title_full Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells
title_fullStr Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells
title_full_unstemmed Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells
title_short Evaluation and validation of a robust single cell RNA-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells
title_sort evaluation and validation of a robust single cell rna-amplification protocol through transcriptional profiling of enriched lung cancer initiating cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320548/
https://www.ncbi.nlm.nih.gov/pubmed/25519510
http://dx.doi.org/10.1186/1471-2164-15-1129
work_keys_str_mv AT rothwelldominicg evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT liyaoyong evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT ayubmahmood evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT tatecatriona evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT newtongillian evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT heyyvonne evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT carterlouise evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT faulknersuzanne evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT moromassimo evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT pepperstuart evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT millercrispin evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT blackhallfiona evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT bertolinigiulia evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT rozluca evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT divecaroline evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells
AT bradyged evaluationandvalidationofarobustsinglecellrnaamplificationprotocolthroughtranscriptionalprofilingofenrichedlungcancerinitiatingcells